55 related articles for article (PubMed ID: 30511279)
1. Effect of active hexose-correlated compound in women receiving adjuvant chemotherapy for breast cancer: a retrospective study.
Hangai S; Iwase S; Kawaguchi T; Kogure Y; Miyaji T; Matsunaga T; Nagumo Y; Yamaguchi T
J Altern Complement Med; 2013 Nov; 19(11):905-10. PubMed ID: 23829813
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
Geyer CE; Blum JL; Yothers G; Asmar L; Flynn PJ; Robert NJ; Hopkins JO; O'Shaughnessy JA; Rastogi P; Puhalla SL; Hilton CJ; Dang CT; Gómez HL; Vukelja SJ; Lyss AP; Paul D; Brufsky AM; Colangelo LH; Swain SM; Mamounas EP; Wolmark N
J Clin Oncol; 2024 Apr; 42(12):1344-1349. PubMed ID: 38335467
[No Abstract] [Full Text] [Related]
3. Real-world data on patients with early breast cancer who were prescribed abemaciclib adjuvant therapy in Japan.
Shimoi T; Pathadka S; Sekine N; Cai Z; Tanizawa Y; Kawaguchi T; Saji S; Yamashita T
Future Oncol; 2024 May; ():1-10. PubMed ID: 38861285
[TBL] [Abstract][Full Text] [Related]
4. A nation-wide multicenter 10-year (1999-2008) retrospective study of chemotherapy in Chinese breast cancer patients.
Li Q; Yang Z; Fan J; He J; Zhang B; Yang H; Xie X; Tang Z; Li H; Qiao Y; Zhang P
Oncotarget; 2017 Sep; 8(44):75864-75873. PubMed ID: 29100275
[TBL] [Abstract][Full Text] [Related]
5. Toxicities Associated with Docetaxel-Based Regimens in the Adjuvant Treatment of Early-Stage Breast Cancer: A Multicenter Prospective Real-Life Experience.
El Rassy E; Ghosn M; Farhat F; Bakouny Z; Assi T; Chahine G; Nasr F; Haddad FG; El Karak F; Kattan J
Breast Care (Basel); 2018 Apr; 13(2):121-125. PubMed ID: 29887789
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.
Untch M; von Minckwitz G
Breast Cancer Res; 2009; 11(2):203. PubMed ID: 19344488
[TBL] [Abstract][Full Text] [Related]
7. Correction: Weight management personas of breast cancer patients undergoing chemotherapy in China: a multi-method study.
Li X; Zhang N; Yang J; Geng Z; Zhou J; Zhang J
BMC Med Inform Decis Mak; 2024 May; 24(1):129. PubMed ID: 38773501
[No Abstract] [Full Text] [Related]
8. Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer.
Mohammad AS; Adkins CE; Shah N; Aljammal R; Griffith JIG; Tallman RM; Jarrell KL; Lockman PR
BMC Cancer; 2018 Dec; 18(1):1225. PubMed ID: 30526520
[TBL] [Abstract][Full Text] [Related]
9. Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial.
Xu F; Fan W; Wang W; Tang W; Yang F; Zhang Y; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2019 Apr; 236(4):1273-1279. PubMed ID: 30519766
[TBL] [Abstract][Full Text] [Related]
10. Severe Photo Toxicity Recalled by Docetaxel.
Johansson EK; Krynitz B; Holmsten M; Klockhoff K; Isaksson Friman E; Xie H
Case Rep Oncol; 2018; 11(3):751-755. PubMed ID: 30519178
[TBL] [Abstract][Full Text] [Related]
11. Q-TWiST Analysis to Assess Benefit-Risk of Pembrolizumab in Patients with PD-L1-Positive Advanced or Metastatic Non-small Cell Lung Cancer.
Huang M; Pietanza MC; Samkari A; Pellissier J; Burke T; Chandwani S; Kong F; Pickard AS
Pharmacoeconomics; 2019 Jan; 37(1):105-116. PubMed ID: 30515719
[TBL] [Abstract][Full Text] [Related]
12. Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Jiang C; Lu Y; Zhang S; Huang Y
Biomed Res Int; 2020; 2020():7961568. PubMed ID: 33381583
[TBL] [Abstract][Full Text] [Related]
13. Sales of anti-cancer medicines; China, Indonesia, Kazakhstan, Malaysia, Philippines and Thailand.
Ferrario A; Stephens P; Guan X; Ross-Degnan D; Wagner A
Bull World Health Organ; 2020 Jul; 98(7):467-474. PubMed ID: 32742032
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational Study.
Xie H; Liu J; Yu S; Chen Y; Zheng M; Deng Y; Wang S; Jiang J; Li Y; Li H; Kang H; Zhang C; Zhang GJ; Su F; Cheng A; Wang S
Adv Ther; 2019 Jan; 36(1):131-146. PubMed ID: 30511279
[TBL] [Abstract][Full Text] [Related]
16. Safety Analysis of Adjuvant Chemotherapy with Docetaxel Administered with or without Anthracyclines to Early Stage Breast Cancer Patients: Combined Results from the Asia- Pacific Breast Initiatives I and II.
Kim SB; Sayeed A; Villalon AH; Shen ZZ; Yau TK; Shah MA; Hou MF; Thuan TV; Ba DN; Chao TY
Asian Pac J Cancer Prev; 2016; 17(2):697-702. PubMed ID: 26925666
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-based adjuvant therapy for breast cancer patients in Asia-Pacific region: Results from 5 years follow-up on Asia-Pacific Breast Initiative-I.
Kim SB; Sayeed A; Villalon AH; Shen ZZ; Shah MA; Hou MF; Nguyen Ba D
Asia Pac J Clin Oncol; 2016 Jun; 12(2):125-32. PubMed ID: 26891467
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Gianni L; Pienkowski T; Im YH; Roman L; Tseng LM; Liu MC; Lluch A; Staroslawska E; de la Haba-Rodriguez J; Im SA; Pedrini JL; Poirier B; Morandi P; Semiglazov V; Srimuninnimit V; Bianchi G; Szado T; Ratnayake J; Ross G; Valagussa P
Lancet Oncol; 2012 Jan; 13(1):25-32. PubMed ID: 22153890
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
